Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (hereinafter “SEBI Listing Regulations”) read with Para A-Part A of Schedule III of the SEBI Listing Regulations, including any statutory modification(s), amendment(s) or re-enactment(s) thereof for the time being in force Ind-Swift Laboratories has informed that it has approved the incorporation of a wholly owned subsidiary in Dubai, United Arab Emirates (UAE) in the name and style of Ind-Swift (Dubai) or such other name as may be approved by the concerned authorities of the UAE. The Company shall further intimate on receipt of Certificate of Incorporation as and when the same is received by the Company.
The above information is a part of company’s filings submitted to BSE.
